Solid or semi-solid therapeutic formulations
US7906125B2 · kind B2 · utility
1Cited by
16References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 18, 2003 |
| Grant date | Mar 15, 2011 |
| Priority date | — |
| Expiry date | Sep 13, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2054
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An injectable or insertable dosage form comprising a biodisintegrable binder and an ablation agent in a concentration effective to cause tissue necrosis. The injectable dosage form is a solid or semi-solid dosage form. Due to the solid or semi-solid nature of the dosage form, retention at the site of injection or insertion is improved, thereby improving delivery efficiency of the ablation agents within the dosage form and/or reducing the nonspecific tissue damage associated with the dosage form.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.